Yiqun Wang
- Speech and Hearing top 10%
-
- Peptidase Inhibition and Analysis 5
-
- Orthopaedic implants and arthroplasty 4
- Cardiac Structural Anomalies and Repair 3
- Knee injuries and reconstruction techniques 2
- Orthopedic Infections and Treatments 2
-
- Pelvic floor disorders treatments 2
-
- Protease and Inhibitor Mechanisms 2
-
- Endometriosis Research and Treatment 2
- Co-authors
- Wing Tak WongKaren S.L. LamYiming LiAimin XuYü HuangHongying YePaul M. VanhoutteJunlei Chang
- Cited by
- Speech and HearingPharmacology
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Yiqun Wang
29 papers receiving 492 citations
Peers
Comparison fields: 5 of 93
- Speech and Hearing 50
- Pharmacology 89
- Pharmacology 40
- Applied Microbiology and Biotechnology 9
- Otorhinolaryngology 16
Countries citing papers authored by Yiqun Wang
This map shows the geographic impact of Yiqun Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yiqun Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yiqun Wang more than expected).
Fields of papers citing papers by Yiqun Wang
This network shows the impact of papers produced by Yiqun Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yiqun Wang. The network helps show where Yiqun Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yiqun Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 13 | |
| 6 | 2022 | 2 | |
| 7 | 2022 | 2 | |
| 8 | 2022 | 8 | |
| 9 | 2022 | 14 | |
| 10 | 2022 | 10 | |
| 11 | 2021 | 13 | |
| 12 | 2020 | 17 | |
| 13 | 2020 | 6 | |
| 14 | 2020 | 3 | |
| 15 | 2019 | 15 | |
| 16 | 2018 | 4 | |
| 17 | 2018 | 35 | |
| 18 | 2015 | 1 | |
| 19 | 2010 | 102 | |
| 20 | 2009 | 139 |
About Yiqun Wang
Yiqun Wang is a scholar working on Applied Microbiology and Biotechnology, Internal Medicine and Cancer Research, having authored 29 papers that have together received 497 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (5 papers), Orthopaedic implants and arthroplasty (4 papers), Cardiac Structural Anomalies and Repair (3 papers), Knee injuries and reconstruction techniques (2 papers), Pelvic floor disorders treatments (2 papers), Orthopedic Infections and Treatments (2 papers), Protease and Inhibitor Mechanisms (2 papers) and Endometriosis Research and Treatment (2 papers). The work is most often cited by research in Speech and Hearing (50 citations), Pharmacology (89 citations) and Pharmacology (40 citations). Yiqun Wang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Wing Tak Wong, Karen S.L. Lam, Yiming Li, Aimin Xu, Yü Huang, Hongying Ye, Paul M. Vanhoutte, Junlei Chang, Ruby L.C. Hoo and Kenneth K.Y. Cheng.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.